Show/hide main menu

Biological Interventions Register

British Association of Dermatologists' Biological Interventions Register (BADBIR)

About the study

The aim of the British Association of Dermatologists' Biological Interventions Register (BADBIR) is to investigate the long-term outcome of psoriasis patients treated with biologic therapy with particular reference to safety. The information obtained will be used to help answer questions about the long-term safety of both biologic and systemic anti-psoriatic therapy.

The study is observational and there are two patient cohorts; one for patients receiving Biologic Therapy and another for patients being treated with Conventional Anti-Psoriatic Systemics. To be eligible to join BADBIR, patients must have within the last six months started or switched to a a biologic or conventional treatment for therapy of their psoriasis

BADBIR aims to recruit 20,000 participants. Patients are followed up for a minimum of five years and data will be collected at routine clinic appointments. Currently BADBIR is open to all dermatology centres across the UK and Eire. Over 150 Trusts have full approval to participate by recruiting psoriasis patients.

For more information please visit the BADBIR website.

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2022 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454